Ingalls & Snyder LLC has filed its 13F form on January 29, 2025 for Q4 2024 where it was disclosed a total value porftolio of $2.55 Billion distributed in 448 stocks.

Among their holdings, we can observe that their the top five positions include companies like: Corcept Therapeutics Inc with a value of $408M, Apple Inc. with a value of $105M, Microsoft Corp with a value of $90.2M, Exxon Mobil Corp with a value of $86.8M, and Berkshire Hathaway Inc Class B with a value of $85.6M.

Examining the 13F form we can see an decrease of $12.8M in the current position value, from $2.56B to 2.55B.

Ingalls & Snyder LLC is based out at New York, NY

Below you can find more details about Ingalls & Snyder LLC portfolio as well as his latest detailed transactions.

Portfolio value $2.55 Billion
Healthcare: $636 Million
Technology: $336 Million
Energy: $332 Million
Financial Services: $330 Million
Industrials: $202 Million
Communication Services: $176 Million
Consumer Cyclical: $174 Million
Consumer Defensive: $109 Million
Other: $200 Million

Stock Holdings Table

Stock Market Cap. Holding Value (Reported) # of Shares. Last Trade Trade History

Summary

  • Portfolio
  • No. of Stocks 448
  • Current Value $2.55 Billion
  • Prior Value $2.56 Billion
  • Filing
  • Period Q4 2024
  • Filing Date January 29, 2025
  • Form Type 13F-HR
  • Activity in Q4 2024
  • New Purchases 18 stocks
  • Additional Purchases 95 stocks
  • Sold out of 0 stocks
  • Reduced holdings in 214 stocks
Track This Portfolio

Track Ingalls & Snyder LLC Portfolio

Follow Ingalls & Snyder LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ingalls & Snyder LLC, based on Form 13F filings with the SEC.

News

Stay updated on Ingalls & Snyder LLC with notifications on news.